CD8A and type 1 diabetes mellitus: Considering the therapeutic potential of TCR-Treg strategies for T1DM, it is imperative to also explore other promising avenues in the broader field of immunotherapy for autoimmune diseases, with CD8+Tregs representing a particularly compelling target for future investigation.